Michael Atkins

Michael B. Atkins serves as Deputy Director of Georgetown-Lombardi Comprehensive Cancer Center and Professor of Oncology and Medicine in Hematology/Oncology at Georgetown University School of Medicine. After receiving his MD from Tufts University School of Medicine and completing his postgraduate training at the Cancer Center at Tufts New England Medical Center Hospital, he has dedicated his career to advancing cancer treatment through immunotherapy research. His expertise focuses on cancer immunotherapy, particularly in treating melanoma and renal cell carcinoma, while developing predictive markers for biological therapy response and exploring antiangiogenic and targeted therapies. His work has significantly contributed to understanding how the immune system can be harnessed to fight cancer, leading to numerous breakthrough treatments. As a leading figure in oncology research, he continues to advance the field through innovative approaches to cancer treatment, combining immunotherapy with other therapeutic strategies to improve patient outcomes.